Document is current
Any future updates will be listed below
-
Authors
Guttman-Yassky, Emma
Simpson, Eric L.
Reich, Kristian
Kabashima, Kenji
Igawa, Ken
Suzuki, Tetsuya
Mano, Hirotaka
Matsui, Takeshi
Esfandiari, Ehsanollah
Furue, Masutaka
-
Funding
Funding for this research was provided by:
Amgen
- License Information
-
More Information
Article History
Received: 10 October 2023
Accepted: 28 November 2023
First Online: 8 January 2024
Declarations
:
: Please see original article for full author disclosures.
: The study protocol was approved by the Institutional Review Board or Independent Ethics Committee and regulatory health authorities in accordance with local regulations before study commencement. The principal investigator and sub-investigators were responsible for conducting the study in full accordance with the Declaration of Helsinki and the Good Clinical Practice Guidelines. All patients provided written informed consent before participating.
